Amidst the continuing prevalence of seasonal respiratory illnesses, such as Covid 19,
Influenza and the common cold
Cyn3rgy Research remains committed to your care and safety. When you come in for your scheduled study research visits, and you may be exhibiting any signs or symptoms of any of the above respiratory illnesses, please wear a mask at your arrival and notify one of our staff members of your symptoms. If you do not have a mask, please ask any Cyn3rgy staff member when you arrive, and we will provide you a mask to wear during your visit. We encourage and appreciate your compliance with this policy, as it protects you as the patient and our staff from spreading any infection.
​

Currently enrolling participants for...

DIAGNOSTIC SAMPLE STUDIES
Study 1 – COVID-19 test study - This clinical study will evaluate the performance of GenBody COVID-19 Ag, intended for use in Point-of-Care setting. Qualifying subjects exhibiting signs and symptoms of COVID-19 will self-take a COVID-19 swab test in the clinic. Qualified participants will be compensated for time and travel.
Study 2 - RSV test study - The objective of this clinical study is to validate the performance of the GenBody RSV Ag relative to an FDA-approved test. Qualified participants will be compensated for time and travel.

​LEARN MORE ​

(RSV)
RESPIRATORY SYNCYTIAL VIRUS
Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. It's so common that most children have been infected with the virus by age 2. Signs and symptoms of respiratory syncytial virus infection most commonly appear about four to six days after exposure to the virus. Cyn3rgy Research is recruiting children who have tested positive for RSV. If you would like to learn more about this clinical trial, please click below or reach out to Cyn3rgy Research for more information.

LEARN MORE 

PNEUMOCOCCAL DISEASE
Pneumococcal Disease is a group of illnesses caused by bacteria called pneumococcus bacteria. It can spread through the air with a cough. The bacteria can enter your child's body through the mouth, throat, or eyes, and may invade parts of the body that are normally free from infection.  Cyn3rgy Research is currently seeking participants for several Pneumococcal Vaccine clinical trials in infants. Please reach out to Cyn3rgy Research to see which study may be the best for your child.
​
LEARN MORE 

VARICELLA-ZOSTER VIRUS
Human alphaherpesvirus 3 (HHV-3), also known as varicella-zoster virus (VZV), is a virus belonging to the family Herpesviridae that causes 2 distinct clinical conditions: varicella (chickenpox) and herpes zoster (shingles). This clinical study is designed to demonstrate the consistency of the immune response to 3 different lots at release potency of GSK’s candidate varicella vaccine (VNS vaccine) and the non-inferiority in terms of immune response to the VNS vaccine compared with Merck’s varicella vaccine, Varivax (VV), when given as a first dose to children 12 to 15 months of age. This clinical study will also evaluate the immunogenicity and the safety of VNS vaccine and VV when co-administered with other childhood vaccines.

LEARN MORE 

ACNE
CLINICAL TRIALS
Cyn3rgy Research is conducting a randomized, double-blind, multi-center comparative effectiveness study of Spironolactone versus Doxycycline Hyclate for the treatment of acne in Women between the ages of 16-40 with mild to severe Acne. Qualified participants will be compensated for time and travel.

LEARN MORE ​

---

MEET THE TEAM

---

 SELECT A STUDY YOU WOULD LIKE TO KNOW MORE ABOUT
• Diagnostic Sample Studies
• RSV Studies
• Pneumococcal Disease Studies
​• Varicella Vaccine Study
• Acne Study

---

Watch our latest videos

Click to set custom HTML

Cyn3rgy Research and Development Staff

Acne Study

Cyn3rgy Investigational Flu Study

ARE YOU INTERESTED IN 
​PARTICIPATING IN A STUDY?
Complete the form. We will contact you when we are enrolling for a particular study that you might be qualified for.

Currently enrolling for...

Diagnostic Sample Studies
Study 1 – COVID-19 test study - This clinical study will evaluate the performance of GenBody COVID-19 Ag, intended for use in Point-of-Care setting. Qualifying subjects exhibiting signs and symptoms of COVID-19 will self-take a COVID-19 swab test in the clinic. Qualified participants will be compensated for time and travel.
Study 2 - RSV test study - The objective of this clinical study is to validate the performance of the GenBody RSV Ag relative to an FDA-approved test. Qualified participants will be compensated for time and travel.

RSV Studies
Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. It's so common that most children have been infected with the virus by age 2. Signs and symptoms of respiratory syncytial virus infection most commonly appear about four to six days after exposure to the virus. Cyn3rgy Research is recruiting children who have tested positive for RSV. If you would like to learn more about this clinical trial, please click below or reach out to Cyn3rgy Research for more information.

Pneumococcal Disease Studies
Pneumococcal Disease is a group of illnesses caused by bacteria called pneumococcus bacteria. It can spread through the air with a cough. The bacteria can enter your child’s body through the mouth, throat, or eyes, and may invade parts of the body that are normally free from infection. Cyn3rgy Research is currently seeking participants for several Pneumococcal Vaccine studies. If you would like to learn more about these enrolling Pneumococcal Disease vaccine studies and how they differentiate, and if your child may qualify, please reach out to Cyn3rgy Research.

Varicella Vaccine Study
If you child is 12-15 months of age and has not had chickenpox or received a vaccination against chickenpox, they may qualify to participate. Compensation for Time and Travel and all Study Related Care is Free. Contact Cyn3rgy Research to learn more.


Acne Study
Acne is one of the most common diseases worldwide, affecting 85% of adolescents. In addition, acne often persists into adulthood, with over 50% of women reporting acne between 20-29 years of age and over 35% of women reporting acne between 30-39 years of age. If you are a female, between the ages of 16-40 presenting with Acne, you may qualify. If you would like to learn more about this clinical trial, please click below or reach out to Cyn3rgy Research for more information.
​

​

Future Studies

Cyn3rgy Research is routinely seeking out new clinical trial opportunities in a variety of disease states and indications. Feel free to periodically check our website for New and Upcoming Studies. This information will be updated routinely to inform patients to what new studies will be starting soon at Cyn3rgy Research. Feel free to reach out to us at any time for real-time updates.

---